U.S. Markets closed

OncoGenex Pharmaceuticals, Inc. (OGXI)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.334409-0.00 (-1.27%)
At close: 3:58PM EDT
People also watch
THLDRPRXONTXOPXACYCC
Full screen
Previous Close0.338700
Open0.328000
Bid0.200000 x 2800
Ask0.515000 x 1000
Day's Range0.328000 - 0.342400
52 Week Range0.328000 - 1.050000
Volume57,656
Avg. Volume150,120
Market Cap10.06M
Beta2.94
PE Ratio (TTM)-0.51
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 months ago

    ETFs with exposure to OncoGenex Pharmaceuticals, Inc. : April 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OncoGenex Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to OGXI-US. Comparing the performance and risk of OncoGenex Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to OncoGenex Pharmaceuticals, Inc. : April 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OncoGenex Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to OGXI-US. Comparing the performance and risk of OncoGenex Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • OncoGenex Pharmaceuticals, Inc. :OGXI-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube3 months ago

    OncoGenex Pharmaceuticals, Inc. :OGXI-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis OncoGenex Pharmaceuticals, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of OncoGenex Pharmaceuticals, Inc. – Immunomedics, Inc., Exelixis, Inc., Celgene Corporation, Ionis Pharmaceuticals, Inc., Bovie Medical Corporation, Teva Pharmaceutical Industries Limited Sponsored ADR, Eli Lilly and Company and Seattle ... Read more (Read more...)